Raphi Levy - 18 Mar 2026 Form 3 Insider Report for Alpha Tau Medical Ltd. (DRTS)

Role
Chief Financial Officer
Signature
/s/ Raphael Levy
Issuer symbol
DRTS
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 18:58:57 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Levy Raphi Chief Financial Officer C/O ALPHA TAU MEDICAL, PO BOX 45044, JERUSALEM, ISRAEL /s/ Raphael Levy 18 Mar 2026 0001968095

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DRTS Ordinary Shares 180,180 18 Mar 2026 Direct
holding DRTS Restricted Share Units 23,996 18 Mar 2026 Direct F1
holding DRTS Restricted Share Units 54,433 18 Mar 2026 Direct F2
holding DRTS Restricted Share Units 49,117 18 Mar 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DRTS Options 18 Mar 2026 Ordinary Shares 325,905 $4.03 Direct F4
holding DRTS Options 18 Mar 2026 Ordinary Shares 36,212 $4.03 Direct F4
holding DRTS Options 18 Mar 2026 Ordinary Shares 45,265 $4.03 Direct F4
holding DRTS Options 18 Mar 2026 Ordinary Shares 90,529 $4.03 Direct F4
holding DRTS Options 18 Mar 2026 Ordinary Shares 45,265 $4.42 Direct F4
holding DRTS Options 18 Mar 2026 Ordinary Shares 86,545 $11.50 Direct F4
holding DRTS Options 18 Mar 2026 Ordinary Shares 70,724 $10.92 Direct F4
holding DRTS Options 18 Mar 2026 Ordinary Shares 80,360 $7.19 Direct F4
holding DRTS Options 18 Mar 2026 Ordinary Shares 328,458 $3.28 Direct F4
holding DRTS Options 18 Mar 2026 Ordinary Shares 301,880 $2.98 Direct F5
holding DRTS Options 18 Mar 2026 Ordinary Shares 267,641 $2.60 Direct F6
holding DRTS Options 18 Mar 2026 Ordinary Shares 158,882 $6.41 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2024, subject to the Reporting Person's continued service.
F2 These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2025, subject to the Reporting Person's continued service.
F3 These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2026, subject to the Reporting Person's continued service.
F4 These are options to acquire ordinary shares, which have fully vested as of the date hereof.
F5 These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2024, subject to the Reporting Person's continued service.
F6 These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2025, subject to the Reporting Person's continued service.
F7 These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2026, subject to the Reporting Person's continued service.